A. Aydınlar, " Why are outcomes different for registry patients enrolled prospectively and retrospectively? Insights from the global anticoagulant registry in the FIELD-Atrial Fibrillation (GARFIELD-AF)," European Heart Journal , vol.4, no.1, pp.27-35, 2018
Aydınlar, A. 2018. Why are outcomes different for registry patients enrolled prospectively and retrospectively? Insights from the global anticoagulant registry in the FIELD-Atrial Fibrillation (GARFIELD-AF). European Heart Journal , vol.4, no.1 , 27-35.
Aydınlar, A., (2018). Why are outcomes different for registry patients enrolled prospectively and retrospectively? Insights from the global anticoagulant registry in the FIELD-Atrial Fibrillation (GARFIELD-AF). European Heart Journal , vol.4, no.1, 27-35.
Aydınlar, ALİ. " Why are outcomes different for registry patients enrolled prospectively and retrospectively? Insights from the global anticoagulant registry in the FIELD-Atrial Fibrillation (GARFIELD-AF)," European Heart Journal , vol.4, no.1, 27-35, 2018
Aydınlar, ALİ. " Why are outcomes different for registry patients enrolled prospectively and retrospectively? Insights from the global anticoagulant registry in the FIELD-Atrial Fibrillation (GARFIELD-AF)." European Heart Journal , vol.4, no.1, pp.27-35, 2018
Aydınlar, A. (2018) . " Why are outcomes different for registry patients enrolled prospectively and retrospectively? Insights from the global anticoagulant registry in the FIELD-Atrial Fibrillation (GARFIELD-AF)." European Heart Journal , vol.4, no.1, pp.27-35.
@article{article, author={ALİ AYDINLAR}, title={ Why are outcomes different for registry patients enrolled prospectively and retrospectively? Insights from the global anticoagulant registry in the FIELD-Atrial Fibrillation (GARFIELD-AF)}, journal={European Heart Journal}, year=2018, pages={27-35} }